WHO ICTRP trial
Effect of monthly administration of 40mg saccharated ferric oxide on hemoglobin…
JPRN-UMIN000026308 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000026308 |
|---|---|
| Public title | Effect of monthly administration of 40mg saccharated ferric oxide on hemoglobin variability and erythropoiesis resistance index in patients with hemodialysis |
| Scientific title | Effect of monthly administration of 40mg saccharated ferric oxide on hemoglobin variability and erythropoiesis resistance index in patients with hemodialysis - Hb variability and ERI by monthly administration of iron in HD patients |
| Primary sponsor | Kitano Hospital, The Tazuke Kofukai Medical Research Institute |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | Japan |
| Conditions | end stage renal disease |
| Interventions | monthly iron administration |
| Registration date | Mar 31, 2021 |
| Target size | 300 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: